GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Earnings Yield %

Novan (NOVNW) Earnings Yield % : N/A% (As of Apr. 19, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Novan Earnings Yield %?

The earnings yield is an indication of how much return shareholders' investment in the company earned over the past 12 months. The higher the earnings yield is, the better.

As of today (2025-04-19), the stock price of Novan is $0.0004. Novan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00. Therefore, Novan's earnings yield of today is N/A%.

The earnings yield does not consider the growth of the business. A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Novan's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Novan Earnings Yield % Calculation

Earnings yield is the reciprocal of the P/E Ratio.

Novan's Earnings Yield for today is calculated as

Earnings Yield=Earnings per Share (Diluted) (TTM)/Share Price
=0.000/0.0004
=N/A %

Novan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Earnings Yield=Net Income /Market Cap

The earnings in the calculation is the Trailing Twelve Months earnings.


Novan  (OTCPK:NOVNW) Earnings Yield % Explanation

If the P/E ratio is an indication of how many years it takes for the company to earn back the stock price shareholders pay to buy the shares, the earnings yield is an indication of how much return shareholders' investment in the company earned over the past 12 months. The higher the earnings yield is, the better.

If a company loses money, the earnings yield is negative. This gives a more straightforward indication that the company is losing money. This is an advantage of using earnings yield instead of the P/E ratio in valuation. For valuation purposes, the P/B Ratio and the P/S Ratio should be used for companies that are losing money.

Like the P/E ratio, the earnings yield can be used to compare investments in different industries. It can even be used to compare the attractiveness of different asset classes such as bonds and cash. Of course, the earnings yield should not be the only factor in deciding which asset classes to invest.

Also similar to the P/E ratio, the earnings yield does not consider the growth of the business. A growing company with the same earnings yield should be more attractive than a company that has the same earnings yield but does not grow.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %.

Be Aware

Just like the P/E Ratio, non-recurring items such as selling part of the business, selling a previous investment, etc., can affect earnings yield dramatically. The earning yield is also a poor indication for cyclical companies. When a cyclical stock has a high earnings yield it is usually at the peak of its cycle.


Novan Earnings Yield % Related Terms

Thank you for viewing the detailed overview of Novan's Earnings Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Q2 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Novan Inc To Host Corporate Update Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report First Quarter 2023 Financial Results on May 15, 2023

By sperokesalga sperokesalga 05-08-2023

Novan, Inc. - Special Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc Fireside Chat Hosted by ROTH Transcript

By GuruFocus Research 02-14-2024

Novan Inc SB206 Clinical Data Update Call Transcript

By GuruFocus Research 02-14-2024